Market Reaction to RFK Jr.'s Nomination

In a notable market movement, shares of leading vaccine manufacturers such as Moderna, Pfizer, and BioNTech experienced a downturn this Tuesday. This shift followed the Senate Finance Committee's decision to move forward with Robert F. Kennedy Jr.'s nomination for the position of Health and Human Services secretary.

Controversial Nomination Advances

The committee's 14-13 party-line vote has propelled the controversial nomination to the Senate floor. Kennedy, a figure known for his critical stance on vaccines, has faced significant backlash over his past remarks regarding vaccine safety.

Impact on Vaccine Stocks

By 10:41 am ET, the financial repercussions were evident: Moderna's stock had decreased by 5.11% to $34.68, BioNTech's shares dropped by 2.97% to $116.26, and Pfizer experienced a 1.77% slip to $25.73.